ScholarX

Journal of Clinical Oncology

Journal Title

  • Journal of Clinical Oncology

ISSN

  • E 1527-7755 | P 0732-183X

Publisher

  • American Society of Clinical Oncology

Listed on(Coverage)

JCR 1997-2023
SJR 1999-2020;2022-2023
CiteScore 2011-2023
SCI 2010-2019
SCIE 2010-2024
CC 2016-2024
SCOPUS 2017-2024
MEDLINE 2016-2024
EMBASE 2016-2024

Active

  • Active

    based on the information

    • SCOPUS:2024-10

Country

  • USA

Aime & Scopes

  • JCO publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readership comprises practicing clinical oncologists, researchers, students, individuals in training, and allied health professionals throughout the world. Members of the American Society of Clinical Oncology as well as nonmember subscribers and patrons of medical libraries globally utilize the groundbreaking research published in each issue of JCO.

Homepage

Article List

401 - 420 out of 1,019 results.

SCIESCOPUS
Interim analysis of the fierce-21 phase 2 (P2) study of vofatamab (B-701), a selective inhibitor of FGFR3, as salvage therapy in metastatic urothelial carcinoma (mUC).

Mellado, B[Mellado, Begona]; Castellano, DE[Castellano, Daniel E.]; Pang, S[Pang, S.]; Urun, Y[Urun, Yuksul]; Park, SH[Park, Se Hoon]; Vaishampayan, UN[Vaishampayan, Ulka N.]; Pal, SK[Pal, Sumanta K.]; Currie, G[Currie, Graeme]; Abella, E[Abella, Esteban]; Vogl, FD[Vogl, Florian D.], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Comprehensive genomic profiling of circulating cell-free DNA (cfDNA) distinguishes focal amplification (amp) from aneuploidy among MET amps in diverse advanced cancer types.

Kumaki, Y[Kumaki, Yuichi]; Ikeda, S[Ikeda, Sadakatsu]; Rich, TA[Rich, Thereasa A.]; Zhao, J[Zhao, Jing]; Yoshino, T[Yoshino, Takayuki]; Cho, BC[Cho, Byoung Chul]; Peled, N[Peled, Nir]; Han, JY[Han, Ji-Youn]; Shiotsu, Y[Shiotsu, Yukimasa]; Franovic, A[Franovic, Aleksandra], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Effect of postoperative adjuvant treatment in the therapeutic management of stage I, morcellated uterine leiomyosarcoma: A Korean multicenter study.

Kim, SI[Kim, Se Ik]; Choi, CH[Choi, Chel Hun]; Kim, K[Kim, Kidong]; Hong, DH[Hong, Deok Ho]; Park, JY[Park, Jeong-Yeol]; Kwon, BS[Kwon, Byung Su]; Lee, KH[Lee, Keun Ho]; Hong, DG[Hong, Dae Gy]; Shin, SJ[Shin, So-Jin]; Park, SI[Park, Sang-Il], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Comprehensive molecular characterization of clinical response in ramucirumab-treated gastric cancer patients: Phase II trial with integrated genomic profiling.

Kim, S[Kim, Seung]; Oh, SY[Oh, Sung Yong]; Park, SH[Park, Se Hoon]; Kim, K[Kim, Kyung]; Park, JO[Park, Joon Oh]; Park, YS[Park, Young Suk]; Kang, WK[Kang, Won Ki]; Lee, J[Lee, Jeeyun]

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Influence of tumor size and Eastern Cooperative Oncology Group performance status (ECOG PS) at baseline on patient (pt) outcomes in lenvatinib-treated radioiodine-refractory differentiated thyroid cancer (RR-DTC).

Wirth, LJ[Wirth, Lori J.]; Leboulleux, S[Leboulleux, Sophie]; Kiyota, N[Kiyota, Naomi]; Tahara, M[Tahara, Makoto]; Muro, K[Muro, Kei]; Ahn, MJ[Ahn, Myung-Ju]; Ando, Y[Ando, Yuichi]; Taylor, MH[Taylor, Matthew H.]; Takahashi, S[Takahashi, Shunji]; Kim, SB[Kim, Sung-Bae], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
End-of-study analysis from the phase Ill, randomized, double-blind, placebo (Pla)-controlled CLEOPATRA study of first-line (1L) pertuzumab (P), trastuzumab (H), and docetaxel (D) in patients (pts) with HER2-positive metastatic breast cancer (MBC).

Swain, SM[Swain, Sandra M.]; Miles, D[Miles, David]; Kim, SB[Kim, Sung-Bae]; Im, YH[Im, Young-Hyuck]; Im, SA[Im, Seock-Ah]; Semiglazov, V[Semiglazov, Vladimir]; Ciruelos, E[Ciruelos, Eva]; Schneeweiss, A[Schneeweiss, Andreas]; Monturus, E[Monturus, Estefania]; Clark, E[Clark, Emma], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746).

Park, YH[Park, Yeon Hee]; Kim, TY[Kim, Tae Yong]; Kim, GM[Kim, Gun Min]; Jung, KH[Jung, Kyung Hae]; Kang, SY[Kang, Seok Yun]; Park, IH[Park, In Hae]; Kim, JH[Kim, Jee Hyun]; Lee, KE[Lee, Kyoung Eun]; Ahn, HK[Ahn, Hee Kyung]; Lee, MH[Lee, Moon Hee], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Antitumor activity and safety of MK-1308 (anti-CTLA-4) plus pembrolizumab (pembro) in patients (pts) with non-small cell lung cancer (NSCLC): Updated interim results from a phase I study.

Perets, R[Perets, Ruth]; Yoh, K[Yoh, Kiyotaka]; Kim, DW[Kim, Dong-Wan]; Bar, J[Bar, Jair]; Ahn, MJ[Ahn, Myung-Ju]; Nagrial, A[Nagrial, Adnan]; Satouchi, M[Satouchi, Miyako]; Rasco, DW[Rasco, Drew W.]; Lee, DH[Lee, Dae Ho]; Spigel, DR[Spigel, David R.], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Efficacy of entrectinib in patients (pts) with solid tumors and central nervous system (CNS) metastases: Integrated analysis from three clinical trials.

Siena, S[Siena, Salvatore]; Doebele, RC[Doebele, Robert Charles]; Shaw, AT[Shaw, Alice Tsang]; Karapetis, CS[Karapetis, Christos Stelios]; Tan, DSW[Tan, Daniel Shao-Weng]; Cho, BC[Cho, Byoung Chul]; Kim, DW[Kim, Dong-Wan]; Ahn, MJ[Ahn, Myung-Ju]; Krebs, M[Krebs, Matthew]; Goto, K[Goto, Koichi], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer: Phase 3 KEYNOTE-181 study.

Shah, MA[Shah, Manish A.]; Adenis, A[Adenis, Antoine]; Enzinger, PC[Enzinger, Peter C.]; Kojima, T[Kojima, Takashi]; Muro, K[Muro, Kei]; Bennouna, J[Bennouna, Jaafar]; Francois, E[Francois, Eric]; Hsu, CH[Hsu, Chih-Hung]; Moriwaki, T[Moriwaki, Toshikazu]; Kim, SB[Kim, Sung-Bae], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Ramucirumab (RAM) for sorafenib intolerant patients with hepatocellular carcinoma (HCC) and elevated baseline alpha fetoprotein (AFP): Outcomes from two randomized phase 3 studies (REACH, REACH2).

Llovet, JM[Llovet, Josep M.]; Yen, CJ[Yen, Chia-Jui]; Finn, RS[Finn, Richard S.]; Kang, YK[Kang, Yoon-Koo]; Kudo, M[Kudo, Masatoshi]; Galle, PR[Galle, Peter R.]; Assenat, E[Assenat, Eric]; Pracht, M[Pracht, Marc]; Lim, HY[Lim, Ho Yeong]; Rau, KM[Rau, Kun-Ming], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Pembrolizumab (pembro) for recurrent head and neck squamous cell carcinoma (HNSCC): Post hoc analyses of phase 3 KEYNOTE-040 prior radiation treatment (RT) and disease state.

Harrington, KJ[Harrington, Kevin J.]; Cohen, EEW[Cohen, Ezra E. W.]; Soulieres, D[Soulieres, Denis]; Dinis, J[Dinis, Jose]; Licitra, LF[Licitra, Lisa F.]; Ahn, MJ[Ahn, Myung-Ju]; Soria, A[Soria, Ainara]; Machiels, JPH[Machiels, Jean-Pascal H.]; Mach, N[Mach, Nicolas]; Mehra, R[Mehra, Ranee], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Genome-wide copy number alteration (CNA) of circulating cell-free DNA (cfDNA) as a prognostic biomarker in esophageal squamous cell carcinoma (ESCC).

Im, HS[Im, Hyeon-Su]; Bang, Y[Bang, Yeonghak]; Jeong, H[Jeong, Hyehyun]; Kang, J[Kang, Jihoon]; Cho, E[Cho, Eunhae]; Jang, JH[Jang, Ja-Hyun]; Lee, J[Lee, Junnam]; Park, SR[Park, Sook Ryun]

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Updated results of a phase IIa study to evaluate the clinical efficacy and safety of erdafitinib in Asian advanced cholangiocarcinoma (CCA) patients with FGFR alterations.

Park, JO[Park, Joon Oh]; Feng, YH[Feng, Yin-Hsun]; Chen, YY[Chen, Yen-Yang]; Su, WC[Su, Wu-Chou]; Oh, DY[Oh, Do-Youn]; Shen, L[Shen, Lin]; Kim, KP[Kim, Kyu-Pyo]; Liu, XF[Liu, Xiufeng]; Bai, YX[Bai, Yuxian]; Liao, HM[Liao, Huimin], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
First-in-human phase I trial of anti-hepatocyte growth factor (HGF) antibody (YYB101) in refractory solid tumor patients: Integrative pathologic-genomic analysis and the final results.

Lee, J[Lee, Jeeyun]; Kim, S[Kim, Seung]; Nam, DH[Nam, Do-Hyun]; Lee, SJ[Lee, Su Jin]; Park, SH[Park, Se Hoon]; Park, JO[Park, Joon Oh]; Lee, JW[Lee, Jeong-Won]; Kim, KM[Kim, Kyoung-Mee]; Lee, H[Lee, Hukeun]; Park, N[Park, Neunggyu], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Phase 1a study results investigating the safety and preliminary efficacy of ABL001 (NOV1501), a bispecific antibody targeting VEGF and DLL4 in metastatic gastrointestinal (GI) cancer.

Lee, J[Lee, Jeeyun]; Kim, S[Kim, Seung]; Lee, SJ[Lee, Su Jin]; Park, SH[Park, Se Hoon]; Park, JO[Park, Joon Oh]; Ha, E[Ha, Eunsin]; Park, DH[Park, Doo-Hong]; Park, N[Park, Neunggyu]; Kim, HK[Kim, Hoon-Kyo]; Lee, SH[Lee, Sang Hoon], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Randomized open-label study of M7824 versus pembrolizumab as first-line (1L) treatment in patients with PD-L1 expressing advanced non-small cell lung cancer (NSCLC).

Ahn, MJ[Ahn, Myung-Ju]; Barlesi, F[Barlesi, Fabrice]; Felip, E[Felip, Enriqueta]; Garon, EB[Garon, Edward B.]; Martin, CM[Marcelo Martin, Claudio]; Mok, TSK[Mok, Tony S. K.]; Vokes, EE[Vokes, Everett E.]; Ojalvo, LS[Ojalvo, Laureen S.]; Koenig, A[Koenig, Andre]; Dussault, I[Dussault, Isabelle], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Biomarker driven phase II umbrella trial study of AZD1775,AZD2014,AZD2811 monotherapy in relapsed small cell lung cancer.

Park, S[Park, Sehhoon]; Shim, J[Shim, Joonho]; Jung, HA[Jung, Hyun Ae]; Sun, JM[Sun, Jong-Mu]; Lee, SH[Lee, Se-Hoon]; Park, WY[Park, Woong-Yang]; Ahn, JS[Ahn, Jin Seok]; Ahn, MJ[Ahn, Myung-Ju]; Park, K[Park, Keunchil]

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
ARTIST 2: Interim results of a phase III trial involving adjuvant chemotherapy and/or chemoradiotherapy after D2-gastrectomy in stage II/III gastric cancer (GC).

Park, SH[Park, Se Hoon]; Zang, DY[Zang, Dae Young]; Han, B[Han, Boram]; Ji, JH[Ji, Jun Ho]; Kim, TG[Kim, Tae Gyu]; Oh, SY[Oh, Sung Yong]; Hwang, IG[Hwang, In Gyu]; Kim, JH[Kim, Jung Hoon]; Shin, D[Shin, Dongbok]; Lim, DH[Lim, Do Hoon], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Efficacy and safety of daratumumab, lenalidomide, and dexamethasone (D-Rd) in relapsed or refractory multiple myeloma (RRMM): Updated subgroup analysis of POLLUX based on cytogenetic risk.

Kaufman, JL[Kaufman, Jonathan L.]; Dimopoulos, MA[Dimopoulos, Meletios A.]; Leiba, M[Leiba, Merav]; Morton, J[Morton, James]; Ho, PJ[Ho, P. Joy]; Kim, K[Kim, Kihyun]; Moreau, P[Moreau, Philippe]; Sutherland, HJ[Sutherland, Heather J.]; Iida, S[Iida, Shinsuke]; Kim, JS[Kim, Jin Seok], et al.

ArticleIssue Date2019CitationJOURNAL OF CLINICAL ONCOLOGY, v.37, no.15PublisherAMER SOC CLINICAL ONCOLOGY
first 21 22 23 24 25 26 27 28 29 30 last
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어